US Map / Virginia
State VA

Clinical Trials in Virginia

Virginia is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Virginia and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 276 actively recruiting studies with Virginia sites out of 276 registered in total. The busiest research areas in Virginia are Breast Cancer, Advanced Solid Tumor, Colorectal Cancer. Leading sponsors running trials in the state include Virginia Commonwealth University, University of Virginia, National Cancer Institute (NCI). By stage, Virginia trials break down as Phase 1 (75), Phase 2 (82), Phase 3 (85), Phase 4 (13).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
276
Recruiting Now
276
← Back to US Map
Top Conditions in Virginia
Breast Cancer (12)Advanced Solid Tumor (9)Colorectal Cancer (8)Solid Tumor (8)Prostate Cancer (8)Advanced Solid Tumors (7)Solid Tumors (6)Cancer (5)Ovarian Cancer (5)Obesity (5)Endometrial Cancer (4)Non-Small Cell Lung Cancer (4)

Frequently Asked Questions — Clinical Trials in Virginia

How many clinical trials are currently recruiting in Virginia?
ClinicalMetric currently tracks 276 actively recruiting clinical trials with at least one location in Virginia. The total number of registered studies—including active but not currently enrolling trials—is 276. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Virginia?
Virginia hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Advanced Solid Tumor, Colorectal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Virginia serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Virginia?
To join a clinical trial in Virginia, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Virginia maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Virginia

NCT05142189 Phase 1
Recruiting
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of B...
Condition
Non-Small Cell Lung Cancer
Enrollment
320 pts
Location
United States, Australia, Germany
Sponsor
BioNTech SE
View Trial →
NCT06765668 Phase 4
Recruiting
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Partici...
Condition
Parkinson Disease
Enrollment
220 pts
Location
United States
Sponsor
Impax Laboratories, LLC
View Trial →
NCT06976268 Phase 2, Phase 3
Recruiting
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment...
Condition
Parkinson Disease
Enrollment
550 pts
Location
United States
Sponsor
Biohaven Therapeutics Ltd.
View Trial →
NCT07593391 Phase 3
Recruiting
An Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid S...
Condition
Phelan-McDermid Syndrome
Enrollment
180 pts
Location
United States
Sponsor
Neuren Pharmaceuticals Limited
View Trial →
NCT06608823 N/A
Recruiting
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
Condition
Aortic Regurgitation
Enrollment
1,016 pts
Location
United States
Sponsor
JenaValve Technology, Inc.
View Trial →
NCT07227246 Phase 3
Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Condition
Intracerebral Hemorrhage
Enrollment
350 pts
Location
United States, Canada, Germany
Sponsor
Joseph Broderick, MD
View Trial →
NCT05626114 Phase 2
Recruiting
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Acti...
Condition
Geographic Atrophy
Enrollment
60 pts
Location
United States, Israel
Sponsor
Genentech, Inc.
View Trial →
NCT06562543 Phase 4
Recruiting
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populati...
Condition
Colorectal Cancer
Enrollment
78 pts
Location
United States, Puerto Rico
Sponsor
Takeda
View Trial →
NCT07529808 Phase 1, Phase 2
Recruiting
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Condition
Gastric Cancer
Enrollment
164 pts
Location
United States
Sponsor
BigHat Biosciences, Inc.
View Trial →
NCT04781140 Phase 4
Recruiting
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Chi...
Condition
Attention-Deficit/Hyperactivity Disorder
Enrollment
286 pts
Location
United States
Sponsor
Supernus Pharmaceuticals, Inc.
View Trial →
NCT04862468 Phase 2
Recruiting
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thro...
Condition
Thrombosis, Deep Vein
Enrollment
80 pts
Location
United States, Ireland, United Kingdom
Sponsor
Mercator MedSystems, Inc.
View Trial →
NCT05382559 Phase 1
Recruiting
A Study of ASP3082 in Adults With Advanced Solid Tumors
Condition
Solid Tumor
Enrollment
681 pts
Location
United States, China, France
Sponsor
Astellas Pharma Inc
View Trial →
NCT03401047 EARLY_Phase 1
Recruiting
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin ...
Condition
Polycystic Ovary Syndrome
Enrollment
37 pts
Location
United States
Sponsor
University of Virginia
View Trial →
NCT04913285 Phase 1
Recruiting
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Posi...
Condition
Solid Tumor, Adult
Enrollment
400 pts
Location
United States, Australia, China
Sponsor
Pierre Fabre Medicament
View Trial →
NCT06964685 N/A
Recruiting
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarctio...
Condition
AMI Cardiogenic Shock
Enrollment
350 pts
Location
United States
Sponsor
Abiomed Inc.
View Trial →
NCT07671989 Phase 4
Recruiting
Period Pills for Menstrual Regulation: A New Reproductive Health Option
Condition
Menstrual Regulation
Enrollment
100 pts
Location
United States
Sponsor
University of California, San
View Trial →
NCT05848297 N/A
Recruiting
Automated Robotic TCD in Traumatic Brain Injury
Condition
Brain Injuries, Traumatic
Enrollment
30 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
View Trial →
NCT07285213 Phase 2
Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Ant...
Condition
Clostridioides Difficile Infection
Enrollment
230 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
View Trial →
NCT06328608 Phase 2, Phase 3
Recruiting
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Child...
Condition
Fabry Disease
Enrollment
22 pts
Location
United States, Austria, France
Sponsor
Chiesi Farmaceutici S.p.A.
View Trial →
NCT04782947 Phase 2, Phase 3
Recruiting
Epidural Stimulation and Resistance Training After SCI
Condition
Spinal Cord Injuries
Enrollment
20 pts
Location
United States
Sponsor
United States Department of De
View Trial →
NCT07645287 Phase 2
Recruiting
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologica...
Condition
HIV-1-infection
Enrollment
175 pts
Location
United States, Australia, Canada
Sponsor
Gilead Sciences
View Trial →
NCT04427384 N/A
Recruiting
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Condition
Brain Tumor, Recurrent
Enrollment
600 pts
Location
United States
Sponsor
GT Medical Technologies, Inc.
View Trial →
NCT04604418 N/A
Recruiting
Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Dise...
Condition
Congenital Heart Disease in Children
Enrollment
10,000 pts
Location
United States, Canada
Sponsor
Boston Children's Hospital
View Trial →
NCT06903923 Phase 2
Recruiting
Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Rece...
Condition
Obesity in Children
Enrollment
120 pts
Location
United States
Sponsor
University of Virginia
View Trial →
NCT05907980 Phase 1
Recruiting
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents ...
Condition
Solid Tumor
Enrollment
209 pts
Location
United States, Japan
Sponsor
Chugai Pharmaceutical
View Trial →
Page 5 of 12 — 276 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology